S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

SXTP 60 Degrees Pharmaceuticals Inc

0.2115

0.0028 (1.34%)

08 May 2024 - Closed

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

60 Degrees Pharmaceuticals (NASDAQ:SXTP)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more 60 Degrees Pharmaceuticals Charts.

60 Degrees Pharmaceuticals (NASDAQ:SXTP)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more 60 Degrees Pharmaceuticals Charts.

60 Degrees Pharmaceuticals Inc News

60 Degrees Pharmaceuticals Receives FDA Comments on Tafenoquine-Babesiosis Clinical Trial Protocol; No Material Changes Required
Thursday 2 May 2024 (6 days ago) • GlobeNewswire Inc.

60 Degrees Pharmaceuticals to Sponsor Pilot Study of Tafenoquine for Treatment of Canine Babesiosis
Wednesday 3 April 2024 (1 month ago) • GlobeNewswire Inc.

60 Degrees Pharmaceuticals Announces Communication from the FDA of Intention to Respond to Tafenoquine-Babesiosis Trial Protocol Submission in April, 2024
Thursday 14 March 2024 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Wednesday 21 February 2024 (3 months ago) • Edgar (US Regulatory)

60 Degrees Pharmaceuticals to Sponsor Pre-Clinical Studies of Tafenoquine Use in Candida spp, Including Candida auris
Tuesday 20 February 2024 (3 months ago) • GlobeNewswire Inc.

60 Degrees Pharmaceuticals Appoints Kristen Landon as Chief Commercial Officer
Thursday 8 February 2024 (3 months ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 3 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 3 February 2024 (3 months ago) • Edgar (US Regulatory)

WallachBeth Capital Announce Closing of 60 Degrees Pharmaceuticals $2.4 Million Public Offering
Thursday 1 February 2024 (3 months ago) • PR Newswire (US)

60 Degrees Pharmaceuticals Announces Closing of $2.4 Million Public Offering
Thursday 1 February 2024 (3 months ago) • GlobeNewswire Inc.

WallachBeth Capital Announces Pricing of 60 Degrees Pharmaceuticals $2.4 Million Public Offering
Wednesday 31 January 2024 (3 months ago) • PR Newswire (US)

60 Degrees Pharmaceuticals Announces Pricing of $2.4 Million Public Offering
Wednesday 31 January 2024 (3 months ago) • GlobeNewswire Inc.

More 60 Degrees Pharmaceuticals Inc News Articles

JP Morgan Chase

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions